Aung Ei T, Fairley Christopher K, Ong Jason J, Chen Marcus Y, Phillips Tiffany R, Tran Julien, Samra Ranjit, Chow Eric P F
Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.
Central Clinical School, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Victoria, Australia.
Open Forum Infect Dis. 2023 Jan 12;10(2):ofad017. doi: 10.1093/ofid/ofad017. eCollection 2023 Feb.
We aimed to examine the incidence of syphilis in men who have sex with men (MSM) and identify subgroups of MSM at a higher risk of syphilis infection.
We conducted a retrospective cohort study of MSM attending a sexual health clinic in Australia, during 2013-2019, who had at least 2 syphilis serological tests during the study period. The incidence of syphilis was expressed as per 100 person-years. A cox regression analysis was conducted to identify risk factors for syphilis.
A total of 24 391 individual MSM (75 086 consultations) were included. A total of 1404 new syphilis cases were diagnosed with an incidence of 3.7/100 person-years (95% confidence interval, 3.5-3.9). Syphilis incidence was higher in MSM with human immunodeficiency virus ([HIV] 9.3/100 person-years) than in MSM taking HIV pre-exposure prophylaxis (PrEP) (6.9/100 person-years) or HIV-negative MSM not taking PrEP (2.2/100 person-years). Risk factors associated with high incidence of syphilis included the following: MSM with HIV (adjusted hazard ratio [aHR] 2.7), MSM taking HIV PrEP (aHR 2.1), past history of syphilis infection (aHR 2.4), injecting drug use (aHR 2.7), condomless anal sex (aHR 1.7), >4 sexual partners in the last 12 months (aHR 1.2), and concurrent sexually transmitted infection (chlamydia and gonorrhoea) (aHR 1.6).
The incidence of syphilis remains high among MSM, particularly in subgroups with associated risk factors for syphilis infections. These data highlight the need for biomedical and behavioral interventions to be targeted to subgroups of MSM at the highest risk of syphilis infection.
我们旨在研究男男性行为者(MSM)中梅毒的发病率,并确定梅毒感染风险较高的MSM亚组。
我们对2013年至2019年期间在澳大利亚一家性健康诊所就诊的MSM进行了一项回顾性队列研究,这些MSM在研究期间至少进行了2次梅毒血清学检测。梅毒发病率以每100人年表示。进行了Cox回归分析以确定梅毒的危险因素。
共纳入24391名个体MSM(75086次咨询)。共诊断出1404例新梅毒病例,发病率为3.7/100人年(95%置信区间,3.5 - 3.9)。感染人类免疫缺陷病毒(HIV)的MSM梅毒发病率(9.3/100人年)高于接受HIV暴露前预防(PrEP)的MSM(6.9/100人年)或未接受PrEP的HIV阴性MSM(2.2/100人年)。与梅毒高发病率相关的危险因素包括:感染HIV的MSM(调整后风险比[aHR] 2.7)、接受HIV PrEP的MSM(aHR 2.1)、既往梅毒感染史(aHR 2.4)、注射吸毒(aHR 2.7)、无保护肛交(aHR 1.7)、过去12个月内有>4个性伴侣(aHR 1.2)以及同时感染性传播感染(衣原体和淋病)(aHR 1.6)。
MSM中梅毒发病率仍然很高,特别是在有梅毒感染相关危险因素的亚组中。这些数据凸显了针对梅毒感染风险最高的MSM亚组进行生物医学和行为干预的必要性。